-
2
-
-
73649099117
-
Acid-base conditions regulate calcium and magnesium homeostasis
-
Rylander R, Tallheden T, Vormann J. Acid-base conditions regulate calcium and magnesium homeostasis. Magnesium Res 2009; 22: 1-4.
-
(2009)
Magnesium Res
, vol.22
, pp. 1-4
-
-
Rylander, R.1
Tallheden, T.2
Vormann, J.3
-
3
-
-
0035755504
-
Prevalence of hypomagnesemia in an unseleced German population of 16'000 individuals
-
Schimatschek HF, Rempis R. Prevalence of hypomagnesemia in an unseleced German population of 16'000 individuals. Magnesium Res 2001; 14: 283-90.
-
(2001)
Magnesium Res
, vol.14
, pp. 283-290
-
-
Schimatschek, H.F.1
Rempis, R.2
-
4
-
-
0036236252
-
Dietary magnesium supply, requirements and recommendations - results from duplicate and balance studies in man
-
Vormann J, Anke M. Dietary magnesium supply, requirements and recommendations - results from duplicate and balance studies in man. J Clin Basic Cardiol 2002; 5: 49-53.
-
(2002)
J Clin Basic Cardiol
, vol.5
, pp. 49-53
-
-
Vormann, J.1
Anke, M.2
-
5
-
-
48249127296
-
The effects of magnesium prophylaxis in migraine without aura
-
Köseoglu Talashoglui A, Grönül S, Kula M. The effects of magnesium prophylaxis in migraine without aura. Magn Res 2008; 21: 101-8.
-
(2008)
Magn Res
, vol.21
, pp. 101-108
-
-
Köseoglu Talashoglui, A.1
Grönül, S.2
Kula, M.3
-
6
-
-
0030012547
-
Prophylaxis of migraine with oral magnesium; results from a prospective, multicentre, placebo-controlled and double blind, randomized study
-
Peikert A, Wilimzig C, Köhne-Volland R. Prophylaxis of migraine with oral magnesium; results from a prospective, multicentre, placebo-controlled and double blind, randomized study. Cephalgia 1996; 16: 257-63. http://dx.doi.org/10.1046/j.1468-2982.1996.1604257.x
-
(1996)
Cephalgia
, vol.16
, pp. 257-263
-
-
Peikert, A.1
Wilimzig, C.2
Köhne-Volland, R.3
-
7
-
-
12244301676
-
Mineral water intake reduces blood pressure among subjects with low urinary magnesium and calcium levels
-
Rylander R, Arnaud MJ. Mineral water intake reduces blood pressure among subjects with low urinary magnesium and calcium levels. BMC Public Health 2004; 4: 56-61. http://dx.doi.org/10.1186/1471-2458-4-56
-
(2004)
BMC Public Health
, vol.4
, pp. 56-61
-
-
Rylander, R.1
Arnaud, M.J.2
-
8
-
-
78851470366
-
Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects - a double-blind, placebocontrolled, randomized trial
-
Mooren PC, Krüger K, Völker K, Golf SW, Wadepuhl M, Kraus A. Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects - a double-blind, placebocontrolled, randomized trial. Diab Obesity Metabol 2011; 13: 281-84. http://dx.doi.org/10.1111/j.1463-1326.2010.01332.x
-
(2011)
Diab Obesity Metabol
, vol.13
, pp. 281-284
-
-
Mooren, P.C.1
Krüger, K.2
Völker, K.3
Golf, S.W.4
Wadepuhl, M.5
Kraus, A.6
-
9
-
-
84889100167
-
Magnesium supplementation to prevent high blood pressure in pregnancy - a randomised placebo control trial
-
Bullarbo M, Ödman N, Nestler A, Nielsen Y, Kolisek M, Vormann J, Rylander R. Magnesium supplementation to prevent high blood pressure in pregnancy - a randomised placebo control trial. Arch Obstetr Gynecol 2013; 288: 1269-74. http://dx.doi.org/10.1007/s00404-013-2900-2
-
(2013)
Arch Obstetr Gynecol
, vol.288
, pp. 1269-1274
-
-
Bullarbo, M.1
Ödman, N.2
Nestler, A.3
Nielsen, Y.4
Kolisek, M.5
Vormann, J.6
Rylander, R.7
-
10
-
-
0024318383
-
Magnesium supplementation during pregnancy: a double-blind randomized controlled clinical trial
-
Sibai BM, Villar MA, Brazy E. Magnesium supplementation during pregnancy: a double-blind randomized controlled clinical trial. Am J Obstetr Gynecol 1989; 161: 115-19. http://dx.doi.org/10.1016/0002-9378(89)90246-9
-
(1989)
Am J Obstetr Gynecol
, vol.161
, pp. 115-119
-
-
Sibai, B.M.1
Villar, M.A.2
Brazy, E.3
-
11
-
-
77749318400
-
Molecular identification of ancient and modern mammalian magnesium transporters
-
Quamme GA. Molecular identification of ancient and modern mammalian magnesium transporters. Am J Physiol Cell Physiol 2010; 298: C407-29. http://dx.doi.org/10.1152/ajpcell.00124.2009
-
(2010)
Am J Physiol Cell Physiol
, vol.298
-
-
Quamme, G.A.1
-
12
-
-
47049100471
-
SLC41A1 is a novel mammalian Mg2+ carrier
-
Kolisek M, Launay P, Beck A, Sponder G, Serafini N, Brenkus M, et al. SLC41A1 is a novel mammalian Mg2+ carrier. J Biol Chem 2008; 283: 16235-47. http://dx.doi.org/10.1074/jbc.M707276200
-
(2008)
J Biol Chem
, vol.283
, pp. 16235-16247
-
-
Kolisek, M.1
Launay, P.2
Beck, A.3
Sponder, G.4
Serafini, N.5
Brenkus, M.6
-
13
-
-
0030027722
-
Increase in magnesium plasma level after orally administered trimagnesium dicitrate
-
Wilimzig C, Latz R, Vierling W, Mutschler E, Trnovec T, Nyulassy S. Increase in magnesium plasma level after orally administered trimagnesium dicitrate. Eur J Clin Pharmacol 1996; 49: 317-23. http://dx.doi.org/10.1007/BF00226334
-
(1996)
Eur J Clin Pharmacol
, vol.49
, pp. 317-323
-
-
Wilimzig, C.1
Latz, R.2
Vierling, W.3
Mutschler, E.4
Trnovec, T.5
Nyulassy, S.6
-
14
-
-
0041989015
-
The availability of magnesium compounds from various preparations
-
Lasserre B and Durlach J (eds). Libbey
-
Jahnen A, Scharrel O, Hesse A. The availability of magnesium compounds from various preparations, In Lasserre B and Durlach J (eds) Magnesium - a relevant ion. Libbey 1991; pp. 377-82.
-
(1991)
Magnesium - a relevant ion
, pp. 377-382
-
-
Jahnen, A.1
Scharrel, O.2
Hesse, A.3
-
15
-
-
0035748332
-
Bioavailability of US commercial magnesium preparations
-
Firoz M, Graber M. Bioavailability of US commercial magnesium preparations. Magnesium Res 2001; 14: 257-62.
-
(2001)
Magnesium Res
, vol.14
, pp. 257-262
-
-
Firoz, M.1
Graber, M.2
-
16
-
-
0025569357
-
Magnesium bioavailablity from magnesium citrate and magnesium oxide
-
Lindberg JS, Zobits MM, Poindexter JR, Pak CY. Magnesium bioavailablity from magnesium citrate and magnesium oxide. J Am Coll Nutr 1990; 9: 48-55. http://dx.doi.org/10.1080/07315724.1990.10720349
-
(1990)
J Am Coll Nutr
, vol.9
, pp. 48-55
-
-
Lindberg, J.S.1
Zobits, M.M.2
Poindexter, J.R.3
Pak, C.Y.4
-
17
-
-
0025806620
-
Magnesium-L-aspartate-HCl and magnesium-oxide: bioavailability in healthy volunteers
-
Mühlbauer B, Schwenk M, Coram WM, Antonin KH, Etienne P, Bieck PR, Douglas FL. Magnesium-L-aspartate-HCl and magnesium-oxide: bioavailability in healthy volunteers. Eur J Clin Pharmacol 1981; 40: 437-38. http://dx.doi.org/10.1007/BF00265863
-
(1981)
Eur J Clin Pharmacol
, vol.40
, pp. 437-438
-
-
Mühlbauer, B.1
Schwenk, M.2
Coram, W.M.3
Antonin, K.H.4
Etienne, P.5
Bieck, P.R.6
Douglas, F.L.7
-
18
-
-
0242405540
-
Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study
-
Walker AF, Marakis G, Christie S, Byng M. Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study. Magnesium Res 2003; 16: 183-91.
-
(2003)
Magnesium Res
, vol.16
, pp. 183-191
-
-
Walker, A.F.1
Marakis, G.2
Christie, S.3
Byng, M.4
-
19
-
-
0025534612
-
Bioavailability of oral magnesium supplementation in female students evaluated from elimination of magnesium in 24-hour urine
-
Bøhmer T, Røseth A, Holm H, Weberg-Teigen S, Wahl L. Bioavailability of oral magnesium supplementation in female students evaluated from elimination of magnesium in 24-hour urine. Magnesium Trace Elem 1990; 9: 272-78.
-
(1990)
Magnesium Trace Elem
, vol.9
, pp. 272-278
-
-
Bøhmer, T.1
Røseth, A.2
Holm, H.3
Weberg-Teigen, S.4
Wahl, L.5
-
20
-
-
84860187534
-
Comparison of magnesium status using X-ray dispersion analysis following magnesium oxide and magnesium citrate treatment of healthy subjects
-
Shechter M, Saad T, Shechter A, Koren-Morag N, Silver BB, Matetzky S. Comparison of magnesium status using X-ray dispersion analysis following magnesium oxide and magnesium citrate treatment of healthy subjects. Magnesium Res 2012; 25: 28-39.
-
(2012)
Magnesium Res
, vol.25
, pp. 28-39
-
-
Shechter, M.1
Saad, T.2
Shechter, A.3
Koren-Morag, N.4
Silver, B.B.5
Matetzky, S.6
|